EMAIL THIS PAGE TO A FRIEND

Journal of medicinal chemistry

Structure-activity relationships of cycloalkylamide derivatives as inhibitors of the soluble epoxide hydrolase.


PMID 21338111

Abstract

Structure-activity relationships of cycloalkylamide compounds as inhibitors of human sEH were investigated. When the left side of amide function was modified by a variety of cycloalkanes, at least a C6 like cyclohexane was necessary to yield reasonable inhibition potency on the target enzyme. In compounds with a smaller cycloalkane or with a polar group on the left side of amide function, no inhibition was observed. On the other hand, increased hydrophobicity dramatically improved inhibition potency. Especially, a tetrahydronaphthalene (20) effectively increased the potency. When a series of alkyl or aryl derivatives of cycloalkylamide were investigated to continuously optimize the right side of the amide pharmacophore, a benzyl moiety functionalized with a polar group produced highly potent inhibition. A nonsubstituted benzyl, alkyl, aryl, or biaryl structure present on the right side of the cycloalkylamide function induced a big decrease in inhibition potency. Also, the resulting potent cycloalkylamide (32) showed reasonable physical properties.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

40199
Methyl tetrahydro-2H-pyran-4-carboxylate, produced by BASF, ≥98.0% (GC)
C7H12O3